Pricing Log in Create free account

Clovis Oncology, Inc. (CLVSQ) vs Pasithea Therapeutics Corp. (KTTA)

Clovis Oncology, Inc. and Pasithea Therapeutics Corp. are both Biotechnology companies. Clovis Oncology, Inc. and Pasithea Therapeutics Corp. are of similar size ($14.2M and $13.7M). Pasithea Therapeutics Corp. has the higher net margin (0.00% vs −189.4%) and the lower return on invested capital (−367.5% vs 0.00%). Across the 15 metrics below, Pasithea Therapeutics Corp. leads on 8 and Clovis Oncology, Inc. on 7.

Valuation

Metric CLVSQ KTTA Biotechnology median
P/E n/m n/m 8.50
P/S 0.10 27.71 9.71
P/B n/m 0.27 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.39 0.64
EV/Sales 3.08 (66.34) 9.21
Earnings yield (2,033.33%) (376.19%) (33.15%)
Free cash flow yield (1,412.40%) (130.85%) (25.50%)

Profitability

Metric CLVSQ KTTA Biotechnology median
Gross margin 72.21% 0.00% 65.16%
Operating margin (155.38%) 0.00% 0.00%
Net margin (189.37%) 0.00% 0.00%
Free cash flow margin (132.19%) 0.00% 0.00%
Return on equity 78.31% (65.49%) (56.36%)
Return on assets (58.94%) (61.97%) (48.04%)
Return on invested capital 0.00% (367.46%) 0.00%

Growth

Metric CLVSQ KTTA Biotechnology median
Revenue growth (TTM) (14.78%) — 6.02%
EPS growth (last fiscal year) 47.72% 77.07% 30.26%
Revenue growth, 5-year CAGR 352.98% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLVSQ KTTA Biotechnology median
Debt to equity (1.05) 0.00 0.00
Current ratio 0.14 26.25 4.72
Net debt to EBITDA (2.16) 2.74 0.96

Dividend

Metric CLVSQ KTTA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CLVSQ KTTA Biotechnology median
Market cap 14.23m 13.70m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack